Sjögren’s syndrome
R. Hal Scofield, MD
Oklahoma Medical Research Foundation
Oklahoma City, Oklahoma, United States
Disclosure(s): Janssen: Advisor or Review Panel Member (Ongoing)
Blake M. Warner, PhD, DDS, MPH
National Institutes of Health
Bethesda, Maryland, United States
Disclosure(s): Astellas: Grant/Research Support (Ongoing); Pfizer: Grant/Research Support (Ongoing)
Sjögren's syndrome is typically associated with a lymphocytic and plasmacytic infiltrate in the salivary, parotid, and lacrimal glands, leading to a sicca syndrome, which is commonly encountered in the rheumatology practice. This immune process often affects non-exocrine organs, including the lung and kidneys. The complication of lymphoma is common in Sjögren's and under-recognized. In this session, recognition, prevention, and management of oral complications, ILD, renal disease, and lymphoma will be discussed.
Speaker: Leslie Laing, PhD,BSc,MSc,DDS – Faculty of Dentistry University of Toronto; Sjogren's Society of Canada; Toronto Public Health Dental and Oral Care Clinics
Speaker: Scott Lieberman, MD, PhD – University of Iowa
Speaker: Sara McCoy, MD, PhD, RhMSUS – University of Wisconsin
Panelist: Leslie Laing, PhD,BSc,MSc,DDS – Faculty of Dentistry University of Toronto; Sjogren's Society of Canada; Toronto Public Health Dental and Oral Care Clinics
Panelist: Scott Lieberman, MD, PhD – University of Iowa
Panelist: Sara McCoy, MD, PhD, RhMSUS – University of Wisconsin